机汇
BU CTSI Vision
The BU CTSI’s vision is to be the strongest possible advocate for and participant in translational research that serves the health needs of our diverse patient populations by creating superior resources that can be integrated with the national CTSA network.
Vision for Workforce Development. A successful research enterprise requires talented, creative investigators working within research teams. The teams should be comprised of trained professionals, faculty and scholars all with clearly defined responsibilities who meet appropriate competencies and have opportunities to grow professionally. Our first global vision is to optimize the success of research teams by providing each member of the team with the necessary training, competencies and accreditation for career development, including participatory and leadership skills in team science. We view this as a particular strength of the BU CTSI.
Vision for a Translational Research Environment. Our vision of a research environment or community rests in the power of inclusiveness. We are committed to the concept that stakeholder members of the BU CTSI Hub have an obligation to identify opportunities to improve, by partnering with each other and with other CTSA hubs. Locally, these goals are described in our Program Plans. Nationally, our goal is to create at least one new inter-Hub collaboration each year. This goal is a standing agenda item in every External Advisory Committee and each monthly Executive Committee meeting in which we explore how to best engage the full spectrum of our community (universities, hospitals, health care settings, scientists, clinicians, patients, advocates, trainees, research teams, foundations, NIH and industry). We actively incentivize and reward new ideas with institutional resources.
6
6
6
BU CTSI Aims
Aim 1. |
Discover, demonstrate, deploy and disseminate novel methods in training that will enhance our entire translational science workforce and create opportunities for advancement. |
Aim 2. |
Develop the most efficient, most representative clinical trials hub possible employing the integrated resources of all our partners. |
Aim 3. |
Effect meaningful multi-directional relationships among all our community stakeholders that strengthen collaborative translational research across the lifespan of our special populations and enable novel approaches to integrating research into health care. |
Aim 4. |
In collaboration with other CTSA hubs, discover, develop and disseminate innovative tools to improve research on treatments and diagnostics that address national health problems: The BU CTSI’s vision is to be the strongest possible advocate for, and participant in, translational research that serves the health needs of our diverse At Risk patient populations by working with our community to create unique resources that can be integrated with and distributed to the national CTSA network. |
BU CTSI Leadership
Meet the CTSI PIs
Megan Bair-Merritt, MD, MSCE, is Professor of Pediatrics (appointment pending May 2019). She leads our ISP Program and developed the highly impactful K Grant Writing Program in our KL2 Component. She is a leading expert on the effects of socioeconomic status and violence on childhood development.
Richard Saitz, MD, MPH, FACP, DFASAM is Professor and Chair of the Community Health Sciences Department, School of Public Health, and a world-renowned expert on addiction science with 250+ publications. He is former head of our PCI Program and now leads our Optional Program in Opioid Treatment. In his role as Chair of Community Health Sciences, he is a key liaison to our Community Advisors